INTRODUCTION
The tumours of adrenal cortex may be detected incidentally at autopsy or following radiologic investigations for other reasons. They can be identified clinically because of hormonal dysfunction or a mass effect. Tumours of adrenal cortex tumours can be categorized into adenomas and carcinomas basing on histopathological evaluation, but the distinction becomes difficult in many cases. An accurate diagnosis is important as the prognosis and therapeutic management for adrenal cortical carcinoma (ACC) and benign tumours vary a lot. However, it is difficult in some cases to distinguish malignant from benign cortical tumours accurately basing on clinical characteristics or histological criteria. Several clinical and histopathologic parameters have been applied by different authors to delineate malignancy in these tumours. Immunohistochemistry is crucial in differentiation of cortical tumours from medullary tumours and
The adrenal cortical tumours in the study were categorized according to the WHO classification. 1 on the basis of morphological study. Weiss criteria were applied for all the cases. 2 A panel of IHC markers including Inhibin, vimentin, and chromogranin was used for confirmation of diagnoses.
RESULTS
Of the 10,246 postoperative surgical specimens received during the period of study, ten cases were reported as adrenal tumours with an incidence of 9.76 in 10,000 cases. Of these ten cases, five were diagnosed as cortical tumors and five as medullary tumours. Female preponderance was observed in the cortical tumours, with women accounting for three cases (60%) while the remaining two cases were seen in men (40%). The tumours were evaluated by gross and microscopic study with application of modified Weiss criteria. Oncocytic adenoma was the histological diagnosis in one case (Case 1) that occurred in a female patient aged 35yrs. The weight of tumour was 30g and its largest dimension was 5cm (Table 1) . Cut surface showed a capsulated, grey brown tumour with nodular configuration (Figure 1a ). Microscopy showed proliferation of exclusively oncocytes with granular eosinophilic cytoplasm. But there was no evidence of nuclear atypia or mitotic activity or necrosis (Figure 1b ). The remaining four cases (Cases no. 2-5) in the study were diagnosed as adrenocortical carcinoma. The age of patients in these cases ranged from 2 years to 65 years, with a sex predilection towards female. The largest diameter of these lesions ranged from 8 cm to13 cm with an average of 11.62 cm sizes and weights ranged from 120 gm to 500 gm with an average of 288.5g (Table 1) .
Gross examination of these four cases showed partly capsulated nodular grey white to grey brown tumour with ragged areas (Figure 2a ). Microscopy showed diffuse distribution of tumour cells with eosinophilic cytoplasm and pleomorphic nuclei (Figure 2b ). Modified Weiss criteria were applied and basing on the total score obtained, all four cases were diagnosed as adrenocortical carcinoma (Table 2) 
DISCUSSION

Clinical presentation of cortical tumours
Adrenal cortical tumours may be functional or nonfunctional, but they usually present with cushing syndrome, osteoporosis, diabetes mellitus, hypertension or gonadal dysfunction. Non-functional tumours may be discovered incidentally or as mass lesions or metastatic deposits. Tumours larger than 5-6 cm manifest flank pain or fever due to compression or necrosis. In women virilisation may be the presenting feature due to androgen secretion. Occasionally malignant cortical tumours may induce gynecomastia in men and menorrhagia in women. Three cases of cortical tumours in our study presented as abdominal masses (Case 1-3). One case manifested precocious puberty in a child (Case 4) while virilisation was the clinical presentation in a woman (Case 5).
Adenoma versus carcinoma
Tumours of adrenal cortex are potentially malignant and distinction between benign and malignant neoplasms is of crucial importance in planning management protocol. However, histopathological diagnosis of malignancy in cortical tumours poses many challenges to the pathologist. Multiple diagnostic criteria have been proposed by different workers to discern malignancy in these lesions. A combination of clinical and histopathoplogical parameters were used by Hough et al to distinguish cortical adenoma from carcinoma. 4 Weiss proposed a system for identifying malignancy in cortical tumours based on nine distinct histopathological criteria. Van Slooten, et al formulated a histopathologic index basing on seven histopathological parameters to distinguish benign from malignant tumours. 5 The threshold for malignancy was lowered in 1989 and the presence of three or more Weiss criteria was considered sufficient to predict malignancy in cortical tumours. 6 Aubert S proposed a simplified system of Weiss criteria and observed that three or more of the nine criteria indicate carcinoma, whereas two or less would suggest an adenoma. 7 Consistent histological features in various systems include the mitotic rate and the presence of vascular or capsular invasion.
In order to assess oncocytic tumours, Biscegha, et al revised the Weiss system and proposed major and minor criteria to define the terms adrenal oncocytic carcinoma (AOC), adrenal oncocytic neoplasm of unknown malignant potential (AONUMP), and Adrenal oncocytoma (AO). 8 If the oncocytic tumour shows one or more major criteria of 1) a mitotic figure of more than 5 mitoses per 50 high-power fields, 2) any atypical mitosis, or 3) any venous invasion), it is reported as AOC. If one or more minor criteria of 1) large size >10 cm and/or >200 g, 2) confluent necrosis, or 3) capsular invasion or 4) sinusoidal invasion), it is categorized as AONUMP. If none of these features is present, the tumour is diagnosed as AO. In our case (Case 1), none of these criteria were present and so this tumour was reported as oncocytic adenoma.
In the process of establishing adrenocortical malignancy, challenges are encountered in differentiating adrenocortical carcinoma from (1) adrenocortical adenoma (2) renal cell carcinoma; and (3) adrenomedullary tumours. One of the most crucial aspects of diagnosis of cortical tumours is distinguishing adenoma from carcinoma.
Differentiating between adenoma and an early stage adrenocortical carcinoma is extremely difficult basing on histopathological features alone in the absence of capsular or angioinvasion or metastasis. Cortical adenomas usually tend to be smaller, more homogeneous, and lacking hemorrhage and necrosis. Surgical resection is generally considered to be curative for lesions less than 50 gm. 9 However, H.S. Tan suggested that adrenal adenomas measuring >4cm in diameter should be followed up with periodic imaging and hormonal evaluation. 10 Adrenal cortical carcinoma (ACC) is a rare but aggressive endocrine malignancy accounting for 0.2% of all cancers. 11 It shows bimodal age distribution with first peak in childhood and a second higher peak in the fourth and fifth decades of life. In the study of Weiss, none of the 24 tumours with two or less of the criteria metastasized or recurred, whereas all but one of the 19 tumours with four or more of the criteria did. 2 The efficacy of this approach was evaluated by independent observers. 7, 13 The scheme introduced by Aubert, et al is a statistically modified system based on the most reliable criteria, wherein some of the Weiss criteria are weighted i.e. the score of 1 has to be multiplied by the weighting factor.
7,14 A score of three or more in both systems, i.e. revised Weiss system and Aubert's modified scheme indicates malignant potential (Table 3) . Increased mitotic activity with by atypical forms and venous invasion have predictive value for recurrence or metastasis. 2, 5, 15, 16 Spindling of the tumour cells also is considered to be highly suggestive of malignancy. 17 However, these schemes may be difficult to apply in case of adrenocortical tumors occurring in childhood, oncocytic variants and tumours with myxoid features. 8, 18, 19 Wienke JA proposed an alternative scheme for adrenocortical tumours in paedeatric age group. 18 The presence of four or more criteria of tumour weight >400g, tumour size >10.5cm, extension of tumour into periadrenal soft tissue/adjacent organs, invasion into vena cava, venous invasion, capsular invasion, presence of tumour necrosis, >15mitoses/20HPF, and presence of atypical mitotic figures is associated with malignancy. 18 In the present study, modified Weiss criteria were applied to identify malignancy in the cortical tumours. Four out of five cortical tumours in our study (Cases 2, 3, 4 5) fulfilled three or more modified criteria of malignancy and were diagnosed as ACC. Of these four cases, two tumours (Cases 4 and 5) exhibited six or more criteria. Apart from high nuclear grade which was present in all the four cases, high mitotic rate of >5/50 HPF, eosinophilic tumour cell cytoplasm, necrosis and capsular invasion were the other most frequent criteria seen in our cases. These findings are in accordance with the observation of RV Lloyd who felt that tumour size, necrosis, mitotic activity with atypical mitoses, invasive growth and high nuclear grade are the most useful criteria to separate carcinoma from adenoma. 19 Immunohistocemical study is imperative in differentiating ACC from adrenal medullary tumours and renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). Positivity for alfa inhibin and Melan A antibody is sensitive though not specific for ACC. 20, 21 Positivity for inhibin is shared by adrenal cortical tumours as well as steroid producing tumours of ovary. Adrenal cortical tumours may show neuroendocrine differentiation and thereby exhibit positivity for synaptophysin and NSE. But in contrast to phaeochromocytoma, adrenal cortical tumours are typically negative for chromogranin A and hence this marker is considered the most reliable marker for distinguishing ACC from adrenal medullary tumours. 12 ACC is negative or weakly positive for cytokeratin and negative for epithelial membrane antigen (EMA) and Carcino embryonic antigen (CEA). But epithelial metastatic deposits to adrenal gland usually show intense cytokeratin immunostaining and positivity for CEA and EMA whereas ACC are negative for these markers.
In our study, all the four cases of adrenocortical carcinomas were positive for inhibin & vimentin. Our results are similar to those obtained by Wick, et al who suggested that vimentin can be used to distinguish between renal cell carcinoma and adrenocortical carcinoma in doubtful cases. 22 Chromogranin was negative in our cases thereby excluding medullary tumours. These observations are in accordance with those of Manoj Jain, et al. 23 
CONCLUSION
Primary neoplasms arising in adrenal cortex are very rare. It is important to distinguish malignant tumours from benign counterparts to plan appropriate management. Histopathology is still the gold standard for diagnosis of adrenal tumours and our findings are in agreement with the view that methodical application of modified Weiss criteria is crucial in identifying adrenocortical malignancy in correlation with clinical and imaging techniques. Immunohistochemistry is of great value, especially in distinguishing between cortical and medullary tumours and differentiating adrenocortical carcinoma from renal cell carcinoma.
